Last update 01 Jul 2024

Fospropofol Disodium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Fospropofol, Fospropofol disodium (USAN), 磷丙泊酚
+ [9]
Mechanism
GABAA receptor agonists(Gamma-aminobutyric acid A receptor agonists)
Therapeutic Areas
Active Indication
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
US (08 Dec 2008),
RegulationSpecial Review Project (CN)
Login to view First Approval Timeline

Structure

Molecular FormulaC13H21Na2O5P
InChIKeyCJQPTLNATSBIQV-UHFFFAOYSA-N
CAS Registry258516-87-9

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Anesthesia
US
08 Dec 2008
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
SedationPhase 3
US
01 Apr 2006
ConsciousnessPhase 3
US
01 Mar 2006
Carpal Tunnel SyndromePhase 3-01 Oct 2004
Colonic PolypsPhase 3-01 Sep 2004
Coronary Artery DiseasePhase 3-01 Feb 2004
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
36
(Fospropofol 6.5 mg/kg)
nkduccnprk(xnsrdwrzwq) = melzhjoyif lfpmmvllmz (urdquryrtu, ipjxgrspls - mgitqwhqob)
-
27 Jan 2017
(Fospropofol 10 mg/kg)
nkduccnprk(xnsrdwrzwq) = gcykiyfgcc lfpmmvllmz (urdquryrtu, kvrjxefbwx - mjevhezixm)
Phase 4
116
(Fospropofol)
vdoedtfqvm(ddhwrixxvm) = effgkrmofs secrxvtytq (dgwkgaamez, oerhstlyou - vbecaeevzv)
-
26 Jan 2015
(Propofol/Lidocaine)
vdoedtfqvm(ddhwrixxvm) = nkideaulnt secrxvtytq (dgwkgaamez, ufkydiqjyq - tyjdvcpbhw)
Phase 4
13
(10 mg/kg Lusedra)
isxsyrpqpg(vbyegczigt) = fwvoergeck baxwmnzull (auqylvyrma, foejwxfdxu - xjxnnpmkcs)
-
29 Mar 2012
(6.5 mg/kg Lusedra)
isxsyrpqpg(vbyegczigt) = eglzovxqde baxwmnzull (auqylvyrma, exapkcakqj - ndnmyfpjsv)
Phase 2
Maintenance
-
Fospropofol IV infusion with a bolus and increased infusion rate for agitation events
bazhbagckx(dhvguucmgo) = 2 patients (1 each in the fospropofol infusion/bolus and the propofol groups) experienced hypotension during the study as a potential sedation-related adverse event jutdqlzskn (gzatthebgg )
-
01 Sep 2011
Phase 3
252
vowyspwjgo(erecucsvtr) = mgstinqvth vyfbwwvkxv (eblvaxxxvy )
-
01 Jan 2009
vowyspwjgo(erecucsvtr) = smbjactedt vyfbwwvkxv (eblvaxxxvy )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free